Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics approval. The study is being conducted in connection with the development of iSTRYM, the firms digital therapeutics platform.

The ethics approval, which comes from Veritas IRB, effectively ensures that processes included in research studies respects participants rights and that they are delivered utilizing the highest standards of ethical practice in human studies. The approval effectively signifies the scientific validation of the study.

The study is being conducted to inform the development of iSTRYM, and how it is built out to best serve therapists, patients, and the psychedelics industry as a whole.

“As we build out iSTRYM to be the largest data repository of psychedelic experiences, we are ensuring that its development is rooted in research proof and a deep understanding of the systems and protocols provided during psychedelic therapy.”

Kelsey Ramsden, CEO of Mind Cure Health

Mind Cure Health last traded at $0.55 on the CSE.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Mindcure Completes Beta Testing, Launches PsyCollage

Mind Cure Health (CSE: MCUR) has completed the beta testing phase for its proprietary bioinformatics...

Tuesday, February 16, 2021, 07:22:53 AM

Mind Cure Doubles Bought Deal Financing To $20 Million

Strong demand continues within the psychedelics space, with Mind Cure Health (CSE: MCUR) announcing earlier...

Friday, January 22, 2021, 02:07:33 PM

Mind Cure To See Nootropics Sold Across North America Via Body Energy Club

Mind Cure Health (CSE: MCUR) this morning released further plans related to the launch of...

Thursday, December 31, 2020, 09:17:25 AM

Mind Cure Appoints Dr Ryan Hartwell As Chief Science Officer

Mind Cure Health (CSE: MCUR) has a new executive. The company this morning announced that...

Tuesday, November 10, 2020, 08:57:19 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM